Zhongnan Medical Journal Press

Home Results

A total of 26 result was found. Results that relate to Small cell lung cancer

The research progress into long non-coding RNA in non-small cell lung cancer

Published on New Medicine 2023,33(3):228-236.
11850 times 3066 times

Juan WANG Xu HAN Ning ZHAO Hong-Tao GUO Xing LIAO Miao JIANG Hao GU

Non-small cell lung cancer Long non-coding RNA Diagnosis Treatment Prognosis
Details
Prognostic value of circulating tumor cells in patients with non-small cell lung cancer: a Meta-analysis

Published on New Medicine 2022,32(1):250-259.
13089 times 3807 times

Ming-Zhen LI Shao-Hua HE Ying-Hui JIN Cheng CHEN Si-Yu YAN Yong-Bo WANG Huan LIU Zhi-Qing ZHOU Han XIAO Rui-Rui YANG Li-Ming TAN

Circulating tumor cell Non-small cell lung cancer Prognosis Meta-analysis
Details
Rapid health technology assessment of anlotinib in treatment of advanced non-small cell lung cancer

Published on New Medicine 2021,31(1):350-356.
15665 times 4240 times

Shan SHEN Jie YANG Yun-Xia LIU Hai-Ming MA Ning HOU

Anlotinib Advanced non-small cell lung cancer Rapid health technology assessment
Details
The effect of lung wedge resection on the surgical parameters and postoperative complications in elderly patients with stage Ib non-small cell lung cancer

Published on Journal of Mathematical Medicine 2023,36(1):36-42.
8315 times 2233 times

Sen LI Guang-Yao MA Xiang-Qun MA Yan-Bing YANG

Non-small cell lung cancer Wedge resection of lung Surgical effect Postoperative complications
Details
A retrospective study on the safety of off-indication use of pyrotinib in patients with non-small cell lung cancer

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1238-1242.
7583 times 2057 times

Hao-Chun TANG Jun MENG Zheng-Zheng XIA Ling-Zhi REN

Non-small cell lung cancer Pyrotinib Adverse drug reaction Safety Off-indication
Details
Effect of platinum-containing regimen combined with chemotherapy on the survival of elderly patients with advanced non-small cell lung cancer

Published on Journal of Mathematical Medicine 2023,36(12):899-905.
11575 times 2321 times

Xue-Xing WANG Yuan HE Jie CHU Yu-Feng WANG

Non-small cell lung cancer Retrospective cohort study Chemotherapy The elderly Survival analysis
Details
A network Meta-analysis of efficacy and safety of different administration routes of recombinant human endostatin in the treatment of non-small cell lung cancer with malignant pleural effusion

Published on Frontiers in Pharmaceutical Sciences 2024,27(4):697-710.
10201 times 1861 times

XU Zhuanzhuan TU Chaochao GONG Zhangqin GUO Yingao TU Mingli

Recombinant human endostatin Administration routes Non-small cell lung cancer Malignant pleural effusion Network Meta-analysis Intravenous drip Pleural effusion
Details
A case of intestinal hemorrhage caused by immune enteritis due to sintilimab

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):818-823.
11275 times 2313 times

MENG Baowei WU Caizhi MA Yongming CHANG Ruitong YANG Xiaogang TIAN Huashan WU Zhiqiang YIN Rui ZHU Zijiang

Sintilimab Non-small cell lung cancer Immune enteritis Intestinal bleeding Adverse drug reactions
Details
First-line treatment with tislelizumab for advanced non-small cell lung cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):790-800.
11606 times 2037 times

LI Wenyan PAN Xiding JIE Qiong LI Yuanyuan TANG Mufei

Tislelizumab Non-small cell lung cancer First-line treatment Rapid health technology assessment
Details
One case of myelosuppression caused by pamiparib in combination with temozolomide in the treatment of small cell lung cancer

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):824-829.
11771 times 2253 times

YANG Yuchen ZHAO Yuting LI Shiqi GONG Jiayu SU Riguga SUN Yanyan CAI Zhihui

Small cell lung cancer Pamiparib Temozolomide Bone marrow suppression Adverse drug reactions
Details
Construction of a nomogram model for the prognosis of advanced non-small cell lung cancer patients treated with microwave ablation combined with immunotherapy based on inflammatory and nutritional indicators

Published on Journal of Mathematical Medicine 2024,37(12):899-911.
13460 times 2062 times

LI Chen XIANG Shiqiang

Non-small cell lung cancer Microwave ablation Immunotherapy Nutritional indicators Inflammatory indicators Nomogram model
Details
Pharmacoeconomic evaluation of third-line treatment of advanced non-small cell lung cancer with anlotinib

Published on Frontiers in Pharmaceutical Sciences 2024,28(4):639-647.
12553 times 1461 times

YUAN Wenjie KANG Shuo WANG Xiaohui GONG Yuan PAN Zhenhua

Anlotinib Pharmacoeconomics Non-small cell lung cancer Cost-utility analysis
Details
Clinical efficacy analysis of cross-line immunotherapy in driver gene-negative advanced non-small cell lung cancer patients

Published on New Medicine 2025,35(2):151-161.
12639 times 2171 times

WANG Yuankun LU Jiahao HU Jing XIE Conghua

Cross-line immunotherapy Non-small cell lung cancer Immune checkpoint inhibitors Prognosis Driver gene-negative
Details
Analysis of influencing factors of cisplatin chemotherapy sensitivity and construction of nomogram model in elderly patients with non-small cell lung cancer

Published on Frontiers in Pharmaceutical Sciences 2025,29(2):284-290.
9125 times 1250 times

HE Ting CHEN Jingjing LI Yuling

Elderly Non-small cell lung cancer Cisplatin Chemotherapy sensitivity Influencing factors Nomogram model Predictive efficiency
Details
Mechanism of Salvia miltiorrhiza against non-small cell lung cancer based on network pharmacology

Published on Frontiers in Pharmaceutical Sciences 2025,29(3):361-373.
7501 times 1529 times

TAO Gan GUO Xiuli HE Fajian WU Qiuji ZHONG Yahua

Salvia miltiorrhiza Traditional Chinese medicine Network pharmacology Molecular docking Non-small cell lung cancer
Details